288 related articles for article (PubMed ID: 29677206)
1. Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats.
Alencar AK; Carvalho FI; Silva AM; Martinez ST; Calasans-Maia JA; Fraga CM; Barreiro EJ; Zapata-Sudo G; Sudo RT
PLoS One; 2018; 13(4):e0195047. PubMed ID: 29677206
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats.
Alencar AK; Pereira SL; Montagnoli TL; Maia RC; Kümmerle AE; Landgraf SS; Caruso-Neves C; Ferraz EB; Tesch R; Nascimento JH; de Sant'Anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Br J Pharmacol; 2013 Jul; 169(5):953-62. PubMed ID: 23530610
[TBL] [Abstract][Full Text] [Related]
3. N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity.
Alencar AK; Pereira SL; da Silva FE; Mendes LV; Cunha Vdo M; Lima LM; Montagnoli TL; Caruso-Neves C; Ferraz EB; Tesch R; Nascimento JH; Sant'anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Int J Cardiol; 2014 May; 173(2):154-62. PubMed ID: 24630383
[TBL] [Abstract][Full Text] [Related]
4. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension.
Pereira SL; Kummerle AE; Fraga CA; Barreiro EJ; Rocha Nde N; Ferraz EB; do Nascimento JH; Sudo RT; Zapata-Sudo G
Eur J Pharmacol; 2013 Feb; 702(1-3):316-22. PubMed ID: 23399770
[TBL] [Abstract][Full Text] [Related]
5. Novel agonist of adenosine receptor induces relaxation of corpus cavernosum in guinea pigs: an in vitro and in vivo study.
Moura VJG; Alencar AKN; Calasans-Maia JA; da Silva JS; Fraga CAM; Zapata-Sudo G; Barreiro EJ; Sudo RT
Urology; 2015 May; 85(5):1214.e17-1214.e21. PubMed ID: 25917739
[TBL] [Abstract][Full Text] [Related]
6. Preventive effect of sildenafil on right ventricular function in rats with monocrotaline-induced pulmonary arterial hypertension.
Yoshiyuki R; Tanaka R; Fukushima R; Machida N
Exp Anim; 2016 Jul; 65(3):215-22. PubMed ID: 26876436
[TBL] [Abstract][Full Text] [Related]
7. Benzenesulfonamide attenuates monocrotaline-induced pulmonary arterial hypertension in a rat model.
Zapata-Sudo G; Pontes LB; da Silva JS; Lima LM; Nunes IK; Barreiro EJ; Sudo RT
Eur J Pharmacol; 2012 Sep; 690(1-3):176-82. PubMed ID: 22728079
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model.
Bhat L; Hawkinson J; Cantillon M; Reddy DG; Bhat SR; Laurent CE; Bouchard A; Biernat M; Salvail D
Eur J Pharmacol; 2018 May; 827():159-166. PubMed ID: 29453947
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension.
Sirmagul B; Ilgin S; Atli O; Usanmaz SE; Demirel-Yilmaz E
Clin Exp Hypertens; 2013; 35(3):220-7. PubMed ID: 22967272
[TBL] [Abstract][Full Text] [Related]
10. Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.
Nakata TM; Tanaka R; Yoshiyuki R; Fukayama T; Goya S; Fukushima R
J Cardiovasc Pharmacol; 2015 Jun; 65(6):640-8. PubMed ID: 25806612
[TBL] [Abstract][Full Text] [Related]
11. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
[TBL] [Abstract][Full Text] [Related]
12. Influence of imatinib at a low dose and sildenafil on pulmonary hypertension in rats.
Jasińska-Stroschein M; Owczarek J; Cicha K; Orszulak-Michalak D
Pharmazie; 2015 Jul; 70(7):477-9. PubMed ID: 26373209
[TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension.
Mouchaers KT; Schalij I; Versteilen AM; Hadi AM; van Nieuw Amerongen GP; van Hinsbergh VW; Postmus PE; van der Laarse WJ; Vonk-Noordegraaf A
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H200-7. PubMed ID: 19395550
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension and survival in rats.
Elias-Al-Mamun M; Satoh K; Tanaka S; Shimizu T; Nergui S; Miyata S; Fukumoto Y; Shimokawa H
Circ J; 2014; 78(4):967-76. PubMed ID: 24553194
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension.
Meghwani H; Prabhakar P; Mohammed SA; Seth S; Hote MP; Banerjee SK; Arava S; Ray R; Maulik SK
J Ethnopharmacol; 2017 Feb; 197():184-194. PubMed ID: 27401289
[TBL] [Abstract][Full Text] [Related]
16. Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension.
Yoshiyuki R; Fukushima R; Tanaka R; Machida N
J Vet Med Sci; 2016 Nov; 78(10):1607-1610. PubMed ID: 27320637
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological relationship of sildenafil and bosentan treatments in rats with monocrotaline induced pulmonary hypertension.
Karpuz D; Hallioglu O; Buyukakilli B; Gurgul S; Balli E; Ozeren M; Tasdelen B
Bratisl Lek Listy; 2017; 118(9):544-551. PubMed ID: 29061062
[TBL] [Abstract][Full Text] [Related]
18. A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil.
Bombicz M; Priksz D; Varga B; Kurucz A; Kertész A; Takacs A; Posa A; Kiss R; Szilvassy Z; Juhasz B
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677661
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat.
Jasińska-Stroschein M; Owczarek J; Wesołowska A; Orszulak-Michalak D
Acta Pharm; 2014 Sep; 64(3):345-53. PubMed ID: 25296680
[TBL] [Abstract][Full Text] [Related]
20. The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.
Jasińska-Stroschein M; Owczarek J; Łuczak A; Orszulak-Michalak D
Pharmacology; 2013; 91(3-4):178-84. PubMed ID: 23428587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
